Femara 2.5 mg tablet

Description

Hormone-Receptor-Positive Breast Cancer Treatment: Femara Tablets are specifically formulated/

to treat Hormone-receptor-positive femara tablets 2.5mg  ONLINE breast cancer, addressing the unique characteristics of this type of.

cancer femara tablets 2.5mg PRICE prevalent in.

postmenopausal women.

Usage Instructions: For personalized dosage femara tablets 2.5mg IN PAKISTAN recommendations.

and guidance on incorporating Femara Tablets into your breast cancer treatment plan, consult with a healthcare professional.

Indications for Breast Cancer Treatment: First-line and adjuvant treatment of hormone-dependent early and advanced breast cancer in postmenopausal women. Extended Adjuvant Treatment.

Treatment of breast cancer in women after 5 years of tamoxifen treatment. Off-label use for fertility purposes: Treatment of infertility in premenopausal women.

Femara acts by inhibition of enzyme aromatase, blocking androgens’ conversion to estrogens.Due to reduced estrogen levels, the drug deprives tumors of hormones necessary for their development.

One tablet of 2.5 mg administered orally once a day. Way of administration: Tablets can be used with/without food; swallowing tablets whole, drinking glass of water. Mode of administration: It is recommended to take Femara at the same time each day for the sake of uniform medicine concentration.

Letrozole is an aromatase inhibitor drug that is used to treat breast cancer in postmenopausal women. Letrozole (CGS 20267) is an oral type II aromatase inhibitor, which was introduced in the literature in 1990.

Active substance: letrozole 2.5mg per film-coated tablet. Other ingredients: lactose monohydrate 61.5 mg per film-coated tablet.